Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
- 1 January 2000
- journal article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 6 (4) , 216-221
- https://doi.org/10.1007/s101560070006
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.Journal of Antimicrobial Chemotherapy, 1999
- Do In Vitro Susceptibility Data Predict the Microbiologic Response to Amphotericin B? Results of a Prospective Study of Patients withCandidaFungemiaThe Journal of Infectious Diseases, 1998
- Evaluation of the susceptibility of pathogenicCandida species to fluconazoleEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitalsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infectionJournal of Antimicrobial Chemotherapy, 1996
- Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study GroupAntimicrobial Agents and Chemotherapy, 1995
- Correlation between in vitro susceptibility ofCandida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993